Targeted Oncology

De-Escalation, Novel Therapy Trends Emerge in Head & Neck Cancer

The management of human papillomavirus (HPV)-positive oropharyngeal cancer is shifting as oncologists balance high cure rates ...

Biomarker test may improve risk assessment for HPV-related throat cancer

Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove ...

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments

Market · GlobeNewswire Inc. The global head and neck cancer (HNC) market is poised for significant growth, with projections ...

More Men Are Getting Diagnosed With HPV-Related Throat Cancers As Doctors Call For Vaccinations

Although this disease only accounts for 3% of all malignant cancer forms in the U.S., this sharp rise has doctors concerned ...

Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer

Strasbourg, France & Schiphol, Netherlands, April 2, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs ...

HPV-positive cancers hide from the immune system, but blocking a single protein could make the tumors treatable

A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows ...

Outrun Therapeutics unveils lead programme targeting HPV positive head and neck cancer and appoints renowned E3 ligase experts to Scientific Advisory Board (SAB)

Lead programme based on a first--in--class small--molecule E6AP ubiquitin ligase inhibition strategy for the treatment of HPV--positive head and neck cancer -- Programme has demonstrated strong in ...

Dear Doctor: HPV has surpassed tobacco use as leading cause of head and neck cancer

The vaccine is best given before the person gets exposed to HPV (although there still may be some benefit in giving the ...